Home › Endometrial Cancer › Wisconsin › La Crosse
Endometrial Cancer clinical trials in La Crosse, WI
3 studies for Endometrial Cancer are looking for participants at sites in and around La Crosse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- Mayo Clinic Health System - Southwest Wisconsin, La Crosse
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Oklahoma City, OK25 studies
- Chicago, IL25 studies
Other studies in La Crosse
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer9 studies
- Breast Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Multiple Myeloma4 studies
- Diffuse Large B-Cell Lymphoma3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Ovarian Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.